USPTO serial 98864807
FLUIDITI
Reviewed by CopyMark Law Group
Status 654
- Filing date
- Status date
- Registration date
- —
- Examiner
- MARCY, AMY ALFIERI
- Law office
- TMEG LAW OFFICE 109
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with FLUIDITI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Francisco, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark A. Jansen
Mark A. Jansen Fenwick & West LLP801 California StreetMountain View, CA 94041United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Software; Downloadable software; Downloadable software for measuring, collecting, viewing, and analyzing health-related data in the field of chronic disease management; Downloadable software for measuring, collecting, viewing, and analyzing health-related data in the field of heart disease; Downloadable software for measuring, collecting, viewing, and analyzing health-related data in the field of kidney disease; Downloadable software for remote management of body weight; remote management of body weight; Downloadable software for remote management of chronic diseases; Downloadable software for remote management of heart disease and heart failure; Downloadable software for remote management of kidney disease; Downloadable software for data analysis in the fields of biomarker information services, disease diagnosis, and efficacy of treatment predictions; Downloadable software for physicians to onboard patients, and track, view, and monitor health-related data of patients; Downloadable software for physicians to onboard patients, and track, view, and monitor health-related data of patients in the field of chronic disease management; Downloadable software for physicians to onboard patients, and track, view, and monitor health-related data of patients in the field of heart disease; Downloadable software for physicians to onboard patients, and track, view, and monitor health-related data of patients in the field of kidney disease; Downloadable software in the nature of a portal for patients to access and view educational information and content; Downloadable software in the nature of a portal for patients to access and view educational medical and health-related information and content in the field of chronic disease management; Downloadable software in the nature of a portal for patients to access and view educational medical and health-related information and content in the field of heart disease; Downloadable software in the nature of a portal for patients to access and view educational medical and health-related information and content in the field of kidney disease; Downloadable software for healthcare professionals; Computer hardware; Computer peripherals | ACTIVE | — |
| 010 | Medical devices; Medical devices for measuring, collecting, and analyzing medical data; Medical devices for managing medical data; Medical devices for assessing, monitoring, and improving cardiac performance and tracking body weight; Medical devices for remote management of chronic diseases and tracking body weight; Medical devices for remote management of heart disease and heart failure; Medical devices for remote management of kidney disease; Medical devices, namely, sensors and scales; Medical devices, namely, sensors and scales for managing medical data; Medical devices, namely, sensors and scales for measuring, collecting, and analyzing medical data; Medical devices, namely sensors and scales for assessing, monitoring, and improving cardiac performance and tracking body weight; Medical devices, namely sensors and scales for remote management of chronic diseases and tracking body weight; Medical devices, namely sensors and scales for remote management of heart disease and heart failure; Medical devices, namely sensors and scales for remote management of kidney disease | ACTIVE | — |
| 042 | Providing temporary use of non-downloadable software; Providing temporary use of non-downloadable software for measuring, collecting, viewing, and analyzing health-related data in the field of chronic disease management; Providing temporary use of non-downloadable software for measuring, collecting, viewing, and analyzing health-related data in the field of heart disease; Providing temporary use of non-downloadable software for measuring, collecting, viewing, and analyzing health-related data in the field of kidney disease; Providing temporary use of non-downloadable software for remote management of body weight; Software as a service (SAAS); Platform as a service (PAAS); Software as a service (SAAS) featuring software for measuring, collecting, viewing, and analyzing health-related data in the field of chronic disease management; Software as a service (SAAS) featuring software for measuring, collecting, viewing, and analyzing health-related data in the field of heart disease; Software as a service (SAAS) featuring software for measuring, collecting, viewing, and analyzing health-related data in the field of kidney disease; Software as a service (SAAS) featuring software for remote management of chronic diseases; Software as a service (SAAS) featuring software for remote management of heart disease and heart failure; Software as a service (SAAS) featuring software for remote management of kidney disease; Providing temporary use of non-downloadable software for data analysis in the fields of biomarker information services, disease diagnosis, and efficacy of treatment predictions; Software as a service (SAAS) featuring software for data analysis in the fields of biomarker information services, disease diagnosis, and efficacy of treatment predictions; Providing temporary use of non-downloadable software for physicians to onboard patients, and track, view, and monitor health-related data of patients; Software as a service (SAAS) featuring software for physicians to onboard patients, and track, view, and monitor their health-related data; Providing temporary use of non-downloadable analytics computer software for physicians to onboard patients, and track, view, and monitor their health-related data in the field of chronic disease management; Providing temporary use of non-downloadable analytics computer software for physicians to onboard patients, and track, view, and monitor their health-related data in the field of heart disease; Providing temporary use of non-downloadable analytics computer software for physicians to onboard patients, and track, view, and monitor their health-related data in the field of kidney disease; Software as a service (SAAS) featuring analytics computer software for physicians to onboard patients, and track, view, and monitor health-related data of patients in the field of chronic disease management; Software as a service (SAAS) featuring analytics computer software for physicians to onboard patients, and track, view, and monitor health-related data of patients in the field of heart disease; Software as a service (SAAS) featuring analytics computer software for physicians to onboard patients, and track, view, and monitor health-related data of patients in the field of kidney disease; Providing temporary use of non-downloadable software in the nature of a portal for patients to access and view educational information and content; Providing temporary use of non-downloadable software in the nature of a portal for patients to access and view educational medical and health-related information and content in the field of chronic disease management; Providing temporary use of non-downloadable software in the nature of a portal for patients to access and view educational medical and health-related information and content in the field of heart disease; Providing temporary use of non-downloadable software in the nature of a portal for patients to access and view educational medical and health-related information and content in the field of kidney disease; Providing temporary use of online non-downloadable software for healthcare professionals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 19, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 8, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 10, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 10, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 10, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 11, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 11, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 11, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 28, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Aug 28, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jun 11, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 11, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 11, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 14, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 26, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 3, 2024 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Dec 3, 2024 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Nov 21, 2024 | NWAP | NEW APPLICATION ENTERED | — |